Concepedia

Suzanne Hendrix

SH

Statistics

Publications

59

Citations

4.5K

H-Index

34

Active since

2003

Affiliations

TetraLogic Pharmaceuticals (United States)(Current)

University of Southern California

Harvard University

Banner Alzheimer’s Institute

Massachusetts General Hospital

Suzanne Hendrix is an author at TetraLogic Pharmaceuticals (United States) specializing in medicine, alzheimer's disease, and neurology.

ORCID

Top concepts

Publications per year

2003–2025

59

Publications

59

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 505 citations · Full text

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

Gordon Wilcock, Sandra E. Black, Suzanne Hendrix et al. · The Lancet Neurology · 2008 · 292 citations

, , +11

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

Hilkka Soininen, Alina Solomon, Pieter Jelle Visser et al. · The Lancet Neurology · 2017 · 237 citations · Full text

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Brian Lawlor, Ricardo Segurado, Seán Kennelly et al. · PLoS Medicine · 2018 · 198 citations · Full text

Sensory, Mechanical, and Microscopic Evaluation of Staling in Low‐Protein and Gluten‐Free Breads

Gene J. Ahlborn, Oscar A. Pike, Suzanne Hendrix et al. · Cereal Chemistry · 2005 · 197 citations

, , +18

Rows per page

1–5 of 59